Cargando…

Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease

Cerebral deposition of abnormally aggregated α-synuclein (αSyn) is a neuropathological hallmark of Parkinson’s disease (PD). PD-associated αSyn (αSyn(PD)) aggregates can act as proteinaceous nuclei (“seeds”) able of self-templated propagation. Since this is strikingly reminiscent to properties of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomzig, Achim, Wagenführ, Katja, Pinder, Phillip, Joncic, Marion, Schulz-Schaeffer, Walter J., Beekes, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068459/
https://www.ncbi.nlm.nih.gov/pubmed/33895878
http://dx.doi.org/10.1007/s00401-021-02312-4
_version_ 1783683032503287808
author Thomzig, Achim
Wagenführ, Katja
Pinder, Phillip
Joncic, Marion
Schulz-Schaeffer, Walter J.
Beekes, Michael
author_facet Thomzig, Achim
Wagenführ, Katja
Pinder, Phillip
Joncic, Marion
Schulz-Schaeffer, Walter J.
Beekes, Michael
author_sort Thomzig, Achim
collection PubMed
description Cerebral deposition of abnormally aggregated α-synuclein (αSyn) is a neuropathological hallmark of Parkinson’s disease (PD). PD-associated αSyn (αSyn(PD)) aggregates can act as proteinaceous nuclei (“seeds”) able of self-templated propagation. Since this is strikingly reminiscent to properties of proteinaceous infectious particles (prions), lessons learned from prion diseases suggest to test whether transferred αSyn(PD) can propagate and induce neurological impairments or disease in a new host. Two studies that addressed this question provided divergent results. Intracerebral (i.c.) injection of Lewy body extracts from PD patients caused cerebral αSyn pathology, as well as nigrostriatal neurodegeneration, of wild-type mice and macaques, with the mice also showing motor impairments (Recasens et al. 2014, Ann Neurol 75:351–362). In contrast, i.c. transmission of homogenates from PD brains did not stimulate, after “> 360” days post-injection (dpi), pathological αSyn conversion or clinical symptoms in transgenic TgM83(+/−) mice hemizygously expressing mutated (A53T) human αSyn (Prusiner et al. 2015, PNAS 112:E5308–E5317). To advance the assessment of possible αSyn(PD) hazards by providing further data, we examined neuropathological and clinical effects upon i.c. transmission of brain, stomach wall and muscle tissue as well as blood from PD patients in TgM83(+/−) mice up to 612 dpi. This revealed a subtle, yet distinctive stimulation of localized αSyn aggregation in the somatodendritic compartment and dystrophic neurites of individual or focally clustered cerebral neurons after challenge with brain and stomach wall homogenates. No such effect was observed with transmitted blood or homogenized muscle tissue. The detected stimulation of αSyn aggregation was not accompanied by apparent motor impairments or overt neurological disease in TgM83(+/−) mice. Our study substantiated that transmitted αSyn(PD) seeds, including those from the stomach wall, are able to propagate in new mammalian hosts. The consequences of such propagation and potential safeguards need to be further investigated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02312-4.
format Online
Article
Text
id pubmed-8068459
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-80684592021-04-26 Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease Thomzig, Achim Wagenführ, Katja Pinder, Phillip Joncic, Marion Schulz-Schaeffer, Walter J. Beekes, Michael Acta Neuropathol Original Paper Cerebral deposition of abnormally aggregated α-synuclein (αSyn) is a neuropathological hallmark of Parkinson’s disease (PD). PD-associated αSyn (αSyn(PD)) aggregates can act as proteinaceous nuclei (“seeds”) able of self-templated propagation. Since this is strikingly reminiscent to properties of proteinaceous infectious particles (prions), lessons learned from prion diseases suggest to test whether transferred αSyn(PD) can propagate and induce neurological impairments or disease in a new host. Two studies that addressed this question provided divergent results. Intracerebral (i.c.) injection of Lewy body extracts from PD patients caused cerebral αSyn pathology, as well as nigrostriatal neurodegeneration, of wild-type mice and macaques, with the mice also showing motor impairments (Recasens et al. 2014, Ann Neurol 75:351–362). In contrast, i.c. transmission of homogenates from PD brains did not stimulate, after “> 360” days post-injection (dpi), pathological αSyn conversion or clinical symptoms in transgenic TgM83(+/−) mice hemizygously expressing mutated (A53T) human αSyn (Prusiner et al. 2015, PNAS 112:E5308–E5317). To advance the assessment of possible αSyn(PD) hazards by providing further data, we examined neuropathological and clinical effects upon i.c. transmission of brain, stomach wall and muscle tissue as well as blood from PD patients in TgM83(+/−) mice up to 612 dpi. This revealed a subtle, yet distinctive stimulation of localized αSyn aggregation in the somatodendritic compartment and dystrophic neurites of individual or focally clustered cerebral neurons after challenge with brain and stomach wall homogenates. No such effect was observed with transmitted blood or homogenized muscle tissue. The detected stimulation of αSyn aggregation was not accompanied by apparent motor impairments or overt neurological disease in TgM83(+/−) mice. Our study substantiated that transmitted αSyn(PD) seeds, including those from the stomach wall, are able to propagate in new mammalian hosts. The consequences of such propagation and potential safeguards need to be further investigated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02312-4. Springer Berlin Heidelberg 2021-04-24 2021 /pmc/articles/PMC8068459/ /pubmed/33895878 http://dx.doi.org/10.1007/s00401-021-02312-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Thomzig, Achim
Wagenführ, Katja
Pinder, Phillip
Joncic, Marion
Schulz-Schaeffer, Walter J.
Beekes, Michael
Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease
title Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease
title_full Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease
title_fullStr Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease
title_full_unstemmed Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease
title_short Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease
title_sort transmissible α-synuclein seeding activity in brain and stomach of patients with parkinson’s disease
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068459/
https://www.ncbi.nlm.nih.gov/pubmed/33895878
http://dx.doi.org/10.1007/s00401-021-02312-4
work_keys_str_mv AT thomzigachim transmissibleasynucleinseedingactivityinbrainandstomachofpatientswithparkinsonsdisease
AT wagenfuhrkatja transmissibleasynucleinseedingactivityinbrainandstomachofpatientswithparkinsonsdisease
AT pinderphillip transmissibleasynucleinseedingactivityinbrainandstomachofpatientswithparkinsonsdisease
AT joncicmarion transmissibleasynucleinseedingactivityinbrainandstomachofpatientswithparkinsonsdisease
AT schulzschaefferwalterj transmissibleasynucleinseedingactivityinbrainandstomachofpatientswithparkinsonsdisease
AT beekesmichael transmissibleasynucleinseedingactivityinbrainandstomachofpatientswithparkinsonsdisease